Shionogi & Co. Ltd. | Ownership
Companies that own Shionogi & Co. Ltd.
Nomura Asset Management Co., Ltd.
17,814,200
5.5%
2,430,700
0.59%
02/15/2018
Wellington Management Co. LLP
13,751,613
4.24%
-3,633,768
0.15%
05/31/2018
Asset Management One Co., Ltd.
13,565,200
4.18%
-3,472,495
0.56%
07/13/2018
BlackRock Fund Advisors
10,506,794
3.24%
1,256,129
0.03%
01/31/2018
Nikko Asset Management Co., Ltd.
9,602,500
2.96%
204,200
0.33%
08/31/2018
Daiwa Asset Management Co. Ltd.
7,429,698
2.29%
-100,902
0.49%
07/31/2018
The Vanguard Group, Inc.
6,994,304
2.16%
40,500
0.01%
07/31/2018
Norges Bank Investment Management
4,906,750
1.51%
698,190
0.04%
12/31/2017
Mitsubishi UFJ Kokusai Asset Management Co., Ltd.
4,097,384
1.26%
238,984
0.51%
07/31/2018
Nissay Asset Management Corp.
3,203,826
0.99%
-682,875
0.95%
01/25/2018
| Address |
3-1-8 Dosho-machi
Osaka Osaka 541
Japan
|
|
Employees
|
- |
| Website |
http://www.shionogi.co.jp |
| Updated |
07/08/2019 |
| Shionogi & Co., Ltd. engages in the research, development, supply, manufacture, and sale of pharmaceutical products. Its products include prescription drugs, over-the-counter drugs, diagnostic regents, medical devices and others. The company was founded by Gisaburo Shiono on March 17, 1878 and is headquartered in Osaka, Japan. |
